{
  "id": "516099a1ea1174af",
  "title": "Capricor rockets 18% after crucial drug trial wins",
  "description": "Capricor Therapeutics found itself in the spotlight on December 3 after delivering news that sent its stock soaring in premarket trading. The small biotech company announced that its experimental therapy for Duchenne muscular dystrophy achieved success in a p\u2026",
  "content": "Capricor Therapeutics found itself in the spotlight on December 3 after delivering news that sent its stock soaring in premarket trading. The small biotech company announced that its experimental the\u2026 [+4469 chars]",
  "source": "Rolling Out",
  "source_url": "https://rollingout.com/2025/12/03/capricor-rockets-18-after-drug-trial-win/",
  "published_at": "2025-12-03T15:20:17Z",
  "fetched_at": "2025-12-06T18:33:06.472112+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "drug",
    "search:drug approval FDA breakthrough"
  ],
  "location": null,
  "raw_data": {
    "source": {
      "id": null,
      "name": "Rolling Out"
    },
    "author": "Tega Egwabor",
    "title": "Capricor rockets 18% after crucial drug trial wins",
    "description": "Capricor Therapeutics found itself in the spotlight on December 3 after delivering news that sent its stock soaring in premarket trading. The small biotech company announced that its experimental therapy for Duchenne muscular dystrophy achieved success in a p\u2026",
    "url": "https://rollingout.com/2025/12/03/capricor-rockets-18-after-drug-trial-win/",
    "urlToImage": "https://rollingout.com/wp-content/uploads/2025/12/shutterstock_2630333769-scaled.jpg",
    "publishedAt": "2025-12-03T15:20:17Z",
    "content": "Capricor Therapeutics found itself in the spotlight on December 3 after delivering news that sent its stock soaring in premarket trading. The small biotech company announced that its experimental the\u2026 [+4469 chars]"
  }
}